Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cenderitide SQ Infusion in Stable Chronic Heart Failure
NCT02359227Phase 2Completed
- Sponsor
- Capricor Therapeutics
- Start
- Jan 2015
- Primary completion
- Apr 2015
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of cenderitide in heart failure (HF), sponsored by Capricor Therapeutics. Started Jan 2015; status: completed.
02
Drugs
cenderitide
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT02359227.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02359227.